Mass General, Infraredx Partner to Explore Cardiovascular Imaging Devices
Infraredx is teaming up with Massachusetts General Hospital and researcher Dr. Gary Tearney to develop new and combination technologies to provide enhanced information about coronary disease in patients.
“Coronary imaging has rapidly evolved over the past decade and has become an important part of the practice of diagnostic and interventional cardiology,” said Tearney, a professor of pathology at Harvard Medical School and founder of the Tearney Lab at the Wellman Center for Photomedicine at Mass General.
He is best known for his work developing optical coherence tomography (OCT), which measures light scattering to image coronary arteries.
Tearney and Infraredx collaborated more than a decade ago on the development of the company’s near-infrared spectroscopy (NIRS) technology. The company’s intravascular TVC Imaging System, which incorporates NIRS and ultrasound, is FDA-approved for identifying lipid core plaques, which are known to complicate stenting procedures and suspected to cause most heart attacks.
For more information, visit
www.infraredx.com.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024